Oral Inhalation Devices Market Growth, Size | Forecast 2030
Oral Inhalation Devices Market Growth, Size | Forecast 2030
Segments - Oral Inhalation Devices Market by Device Type (Nebulizer, Metered Dose Inhaler, Dry Powder Inhaler, and Others [soft mist inhalers and smart inhalers]), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others [cystic fibrosis and idiopathic pulmonary fibrosis]), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy), and by Region (North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021-2030
Upcoming
| Report ID :HC-5338
| 4.4 Rating
| 74 Reviews
| 304 Pages
| Format :
Report Description
Market Outlook:
The Global Oral Inhalation Devices Market was estimated at USD 43,743.3 Million in 2021 and is anticipated to reach USD 77,666.6 Million by 2030, expanding at a CAGR of 6.5% during the forecast period.
An inhaler is a device used to administer medication to the lungs and airways. It is primarily used to treat or prevent illnesses related to the airways such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma. When inhaled, the medicine quickly reaches the airways and chances of absorption of the medicine into the bloodstream is substantially reduced. Pulmonary delivery is an acceptable route for systemic administration, as the medication is quickly absorbed through the large surface area of the alveolar region, the rich vasculature, and the thin air-blood barrier along, while avoiding first-pass metabolism.
Macro-economic Factors
Rising GDPs of Emerging Economies
An emerging economy refers to a country that is in the process of developing its economy to become advanced. Emerging economies such as Brazil, Russia, India, China (BRIC), and other countries in Latin America and Southeast Asia are key markets for the pharmaceutical industry. The increasing availability of medical infrastructure and rising government spending on healthcare infrastructure developments across major economies are key factors contributing to their GDPs. Thus, rising GDPs of emerging economies play a crucial role in the expansion of the market.
R&D activities
Increasing investments from key market players in research and development (R&D) activities and a rising focus on product innovations are expected to trigger the demand for the oral inhalation devices market in the coming years. Key market players focus on technological advancements to meet the demand from several industries, such as the healthcare industry. Companies are engaging in R&D to develop technologically advanced products to gain a competitive edge.
Market Dynamics
Market Driver- Increasing Healthcare Initiatives from International Organizations
Increasing collaboration between various healthcare organizations and rising government initiatives to overcome chronic respiratory diseases are the major factors driving the global market for oral inhalation devices. In 2021, Global Initiative for Asthma (GINA) took various initiatives to enhance the diagnosis and management of asthma among patients. The aim of GINA is to improve the diagnosis, management, and prevention of asthma by providing an up-to-date strategy, tools, and practical resources for clinicians globally.
Market Driver- Growing Introduction of Effective Oral Inhalation Devices
Manufacturers are developing several innovative oral inhalation devices for the treatment of chronic respiratory diseases. Oral inhalation devices are widely considered the preferred therapy equipment, which are extensively recommended by doctors and medical professionals. The introduction of advanced oral inhalation devices helps to improve lung functioning and breathing by alleviating the symptoms of chronic respiratory diseases such as bronchitis, asthma, emphysema, and chronic obstructive pulmonary disease (COPD).
Market Restraint- High Cost of Inhalers
High cost of inhalers is a key restraining factor that is expected to hinder the market during the forecast period. Cost of an inhaler is high, due to the rising preferences for brand-name inhalers over generic inhalers among patients. For instance, the average cost of a brand-name asthma inhaler without insurance is USD 292.91. Thus, the high cost of inhalers, especially in rapidly developing countries such as China, India, and Brazil, is estimated to restrain the market growth.
Market Opportunity- Technological Advancements
Rising technological advancements in inhaler/formulation design and in producing better-inhaled products offer lucrative opportunities for market players. Introduction of technologically advanced mesh nebulizers has created many opportunities for the firms such as PARI Pharma and Vectura Group, as Many pharmaceutical companies use mesh nebulizers for drug development.
Scope of the Report
The report on the global oral inhalation devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Oral Inhalation Devices Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2015–2020 |
|
Forecast Period |
2022–2030 |
|
Segmentation |
By Device Type (Nebulizer, Metered Dose Inhaler, Dry Powder Inhaler, Others [soft mist inhalers and smart inhalers]), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Others [cystic fibrosis and idiopathic pulmonary fibrosis]), and By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered |
Koninklijke Philips N.V.; AptarGroup, Inc.; Chiesi Farmaceutici S.p.A.; OMRON Healthcare, Inc.; and Recipharm AB |
Segmental Outlook
Based on device type, the oral inhalation devices market is segmented into nebulizers, metered dose inhalers (MDI), dry powder inhalers (DPI), and others (soft mist inhalers and smart inhalers). The nebulizers segment is projected to expand at a rapid pace during the forecast period, due to increasing demand for home healthcare devices. Sales of jet nebulizers are expected to increase in the coming years, due to their low cost. Nebulizers are easy to use and do not require any specific technique to be administered.
Based on application, the global oral inhalation devices market is segmented into asthma, chronic obstructive pulmonary disease (COPD), and others (cystic fibrosis and idiopathic pulmonary fibrosis). The asthma segment is projected to expand at a significant CAGR during the forecast period, due to the increasing number of asthma cases on account of the rising air pollution. Increasing focus on advanced inhalers for asthma treatment is a major factor for the growth of the market.
Based on distribution channel, the global oral inhalation devices market is segmented into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment is expected to hold an XX% share of the market during the forecast period. The hospital pharmacy segment is expected to hold a substantial share of the market during the forecast period, due to in-person recommendations and cares from pharmacists. The online pharmacy segment is fast-growing segment, due to the increasing technological innovations in the supply of contactless medicine, which was helpful, especially during the pandemic.
Regional Outlook
On the basis of region, the global oral inhalation devices market is segmented into North America, Europe, APAC, Latin America, and the Middle East & Africa. The market in North America is projected to expand at a substantial CAGR during the forecast period. North America is expected to maintain its dominance in the global market during the forecast period, due to increasing demand for oral inhalation devices from major sectors such as hospitals, clinics, and laboratories in the region.
The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. Oral inhalation devices are used to treat patients suffering from asthma and COPD in countries such as China and India, which is expected to aid market growth in the region during the forecast period.
The market in Europe is predicted to expand at a significant rate, due to the increasing number of chronic respiratory diseases among the people in the region.
Latin America and the Middle East & Africa (MEA) are projected to hold a considerable share of the global oral inhalation devices market. Rising use of oral inhalation devices in various respiratory treatments is expected to boost the market in these regions in the coming years.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Oral Inhalation Devices Market
- Historical, Current, and Projected Market Size in terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints, and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on global oral inhalation devices market performance
Segments
By Device Type
- Nebulizer
- Metered Dose Inhaler
- Dry Powder Inhaler
- Others
- Soft Mist Inhalers
- Smart Inhalers
By Application
- Professional Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Others
- Cystic Fibrosis
- Idiopathic Pulmonary Fibrosis
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Market Players Profiled in the Report
- Koninklijke Philips N.V.
- AptarGroup, Inc.
- Chiesi Farmaceutici S.p.A.
- OMRON Healthcare, Inc.
- Recipharm AB
- KINDEVA DRUG DELIVERY
- Beurer GmbH
- PARI Respiratory Equipment, Inc.
- Vincent Medical Holdings Limited
- Trudell Medical International
Competitive Landscape
- Manufacturers operating in the global oral inhalation devices market include Koninklijke Philips N.V.; AptarGroup, Inc.; Chiesi Farmaceutici S.p.A.; OMRON Healthcare, Inc.; and Recipharm AB.
- Market Players are pursuing key strategies such as acquisitions, collaborations, and geographic expansion where a potential opportunity arises for the oral inhalation devices market.
Frequently Asked Questions
Additional company profiles can be provided on request
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Rising prevalence of chronic respiratory diseases (CRDs), increasing healthcare initiatives from international organizations, and the growing introduction of effective oral inhalation devices are the factors driving the growth of the oral inhalation devices market.
According to this Growth Market Reports report, the oral inhalation devices market is likely to register a CAGR of 6.5% during the forecast period 2022-2030, with an anticipated valuation of USD 77,666.6 Million by the end of 2030.
Hospital Pharmacy is the major distribution channel for oral inhalation devices.
Rising GDPs of emerging economies, R&D activities, and improving healthcare infrastructure are expected to act as macroeconomic factors for the market.
Major manufacturers include Koninklijke Philips N.V.; AptarGroup, Inc.; Chiesi Farmaceutici S.p.A.; OMRON Healthcare, Inc.; Recipharm AB; and others.
COVID-19 marks a positive impact on the global oral inhalation devices market. The outbreak of coronavirus disease in 2019 (COVID-19) had a positive impact on the global oral inhalation devices market. The spread of COVID-19 required the adoption of preventive measures for the spread of the disease. These factors drove the demand for oral inhalation devices in hospitals and clinics.
In addition to market size (in USD Million) Company Market Share (in % for the base year 2021), innovation and technological advancement overview, current and future trends, a detailed overview and current potential trends for different categories of inhalation devices, acquisition, and mergers licensing deals, new product launches.
The base year considered for the Global Oral Inhalation Devices Market report is 2021. The complete analysis period is 2020 to 2030, wherein, 2015, and 2020 are the historic years, and the forecast is provided from 2022 to 2030.
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Inhalation Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Inhalation Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Inhalation Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Inhalation Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Inhalation Devices Market Size & Forecast, 2015-2030
4.5.1 Oral Inhalation Devices Market Size and Y-o-Y Growth
4.5.2 Oral Inhalation Devices Market Absolute $ Opportunity
4.6 Global Oral Inhalation Devices Market: Current and Future Trends
4.7 Global Oral Inhalation Devices Market: Pricing Analysis by Region (Nebulizer, Metered Dose Inhaler, Dry Powder Inhaler, Others)
Chapter 5 Global Oral Inhalation Devices Market Analysis and Forecast By Device Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Device Type
5.1.2 Basis Point Share (BPS) Analysis By Device Type
5.1.3 Absolute $ Opportunity Assessment By Device Type
5.2 Oral Inhalation Devices Market Size Forecast By Device Type
5.2.1 Nebulizer
5.2.2 Metered Dose Inhaler
5.2.3 Dry Powder Inhaler
5.2.4 Others
5.3 Market Attractiveness Analysis By Device Type
Chapter 6 Global Oral Inhalation Devices Market Analysis and Forecast By Application
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Application
6.1.2 Basis Point Share (BPS) Analysis By Application
6.1.3 Absolute $ Opportunity Assessment By Application
6.2 Oral Inhalation Devices Market Size Forecast By Application
6.2.1 Asthma
6.2.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.3 Others
6.3 Market Attractiveness Analysis By Application
Chapter 7 Global Oral Inhalation Devices Market Analysis and Forecast By Distribution Channel
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Distribution Channel
7.1.2 Basis Point Share (BPS) Analysis By Distribution Channel
7.1.3 Absolute $ Opportunity Assessment By Distribution Channel
7.2 Oral Inhalation Devices Market Size Forecast By Distribution Channel
7.2.1 Retail Pharmacy
7.2.2 Hospital Pharmacy
7.2.3 Online Pharmacy
7.3 Market Attractiveness Analysis By Distribution Channel
Chapter 8 Global Oral Inhalation Devices Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Oral Inhalation Devices Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Oral Inhalation Devices Analysis and Forecast
10.1 Introduction
10.2 North America Oral Inhalation Devices Market Size Forecast by Country
10.2.1 U.S.
10.2.1.1 By Device Type
10.2.1.2 By Application
10.2.1.3 By Distribution Channel
10.2.2 Canada
10.2.2.1 By Device Type
10.2.2.2 By Application
10.2.2.3 By Distribution Channel
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Oral Inhalation Devices Market Size Forecast By Device Type
10.6.1 Nebulizer
10.6.2 Metered Dose Inhaler
10.6.3 Dry Powder Inhaler
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis By Device Type
10.8 Absolute $ Opportunity Assessment By Device Type
10.9 Market Attractiveness Analysis By Device Type
10.10 North America Oral Inhalation Devices Market Size Forecast By Application
10.10.1 Asthma
10.10.2 Chronic Obstructive Pulmonary Disease (COPD)
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis By Application
10.12 Absolute $ Opportunity Assessment By Application
10.13 Market Attractiveness Analysis By Application
10.14 North America Oral Inhalation Devices Market Size Forecast By Distribution Channel
10.14.1 Retail Pharmacy
10.14.2 Hospital Pharmacy
10.14.3 Online Pharmacy
10.15 Basis Point Share (BPS) Analysis By Distribution Channel
10.16 Absolute $ Opportunity Assessment By Distribution Channel
10.17 Market Attractiveness Analysis By Distribution Channel
Chapter 11 Europe Oral Inhalation Devices Analysis and Forecast
11.1 Introduction
11.2 Europe Oral Inhalation Devices Market Size Forecast by Country
11.2.1 Germany
11.2.1.1 By Device Type
11.2.1.2 By Application
11.2.1.3 By Distribution Channel
11.2.2 France
11.2.2.1 By Device Type
11.2.2.2 By Application
11.2.2.3 By Distribution Channel
11.2.3 Italy
11.2.3.1 By Device Type
11.2.3.2 By Application
11.2.3.3 By Distribution Channel
11.2.4 U.K.
11.2.4.1 By Device Type
11.2.4.2 By Application
11.2.4.3 By Distribution Channel
11.2.5 Spain
11.2.5.1 By Device Type
11.2.5.2 By Application
11.2.5.3 By Distribution Channel
11.2.6 Russia
11.2.6.1 By Device Type
11.2.6.2 By Application
11.2.6.3 By Distribution Channel
11.2.7 Rest of Europe
11.2.7.1 By Device Type
11.2.7.2 By Application
11.2.7.3 By Distribution Channel
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Oral Inhalation Devices Market Size Forecast By Device Type
11.6.1 Nebulizer
11.6.2 Metered Dose Inhaler
11.6.3 Dry Powder Inhaler
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis By Device Type
11.8 Absolute $ Opportunity Assessment By Device Type
11.9 Market Attractiveness Analysis By Device Type
11.10 Europe Oral Inhalation Devices Market Size Forecast By Application
11.10.1 Asthma
11.10.2 Chronic Obstructive Pulmonary Disease (COPD)
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis By Application
11.12 Absolute $ Opportunity Assessment By Application
11.13 Market Attractiveness Analysis By Application
11.14 Europe Oral Inhalation Devices Market Size Forecast By Distribution Channel
11.14.1 Retail Pharmacy
11.14.2 Hospital Pharmacy
11.14.3 Online Pharmacy
11.15 Basis Point Share (BPS) Analysis By Distribution Channel
11.16 Absolute $ Opportunity Assessment By Distribution Channel
11.17 Market Attractiveness Analysis By Distribution Channel
Chapter 12 Asia Pacific Oral Inhalation Devices Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Oral Inhalation Devices Market Size Forecast by Country
12.2.1 China
12.2.1.1 By Device Type
12.2.1.2 By Application
12.2.1.3 By Distribution Channel
12.2.2 Japan
12.2.2.1 By Device Type
12.2.2.2 By Application
12.2.2.3 By Distribution Channel
12.2.3 South Korea
12.2.3.1 By Device Type
12.2.3.2 By Application
12.2.3.3 By Distribution Channel
12.2.4 India
12.2.4.1 By Device Type
12.2.4.2 By Application
12.2.4.3 By Distribution Channel
12.2.5 Australia
12.2.5.1 By Device Type
12.2.5.2 By Application
12.2.5.3 By Distribution Channel
12.2.6 South East Asia (SEA)
12.2.6.1 By Device Type
12.2.6.2 By Application
12.2.6.3 By Distribution Channel
12.2.7 Rest of Asia Pacific (APAC)
12.2.7.1 By Device Type
12.2.7.2 By Application
12.2.7.3 By Distribution Channel
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Oral Inhalation Devices Market Size Forecast By Device Type
12.6.1 Nebulizer
12.6.2 Metered Dose Inhaler
12.6.3 Dry Powder Inhaler
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis By Device Type
12.8 Absolute $ Opportunity Assessment By Device Type
12.9 Market Attractiveness Analysis By Device Type
12.10 Asia Pacific Oral Inhalation Devices Market Size Forecast By Application
12.10.1 Asthma
12.10.2 Chronic Obstructive Pulmonary Disease (COPD)
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis By Application
12.12 Absolute $ Opportunity Assessment By Application
12.13 Market Attractiveness Analysis By Application
12.14 Asia Pacific Oral Inhalation Devices Market Size Forecast By Distribution Channel
12.14.1 Retail Pharmacy
12.14.2 Hospital Pharmacy
12.14.3 Online Pharmacy
12.15 Basis Point Share (BPS) Analysis By Distribution Channel
12.16 Absolute $ Opportunity Assessment By Distribution Channel
12.17 Market Attractiveness Analysis By Distribution Channel
Chapter 13 Latin America Oral Inhalation Devices Analysis and Forecast
13.1 Introduction
13.2 Latin America Oral Inhalation Devices Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Oral Inhalation Devices Market Size Forecast By Device Type
13.6.1 Nebulizer
13.6.2 Metered Dose Inhaler
13.6.3 Dry Powder Inhaler
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis By Device Type
13.8 Absolute $ Opportunity Assessment By Device Type
13.9 Market Attractiveness Analysis By Device Type
13.10 Latin America Oral Inhalation Devices Market Size Forecast By Application
13.10.1 Asthma
13.10.2 Chronic Obstructive Pulmonary Disease (COPD)
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis By Application
13.12 Absolute $ Opportunity Assessment By Application
13.13 Market Attractiveness Analysis By Application
13.14 Latin America Oral Inhalation Devices Market Size Forecast By Distribution Channel
13.14.1 Retail Pharmacy
13.14.2 Hospital Pharmacy
13.14.3 Online Pharmacy
13.15 Basis Point Share (BPS) Analysis By Distribution Channel
13.16 Absolute $ Opportunity Assessment By Distribution Channel
13.17 Market Attractiveness Analysis By Distribution Channel
Chapter 14 Middle East & Africa (MEA) Oral Inhalation Devices Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Oral Inhalation Devices Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Oral Inhalation Devices Market Size Forecast By Device Type
14.6.1 Nebulizer
14.6.2 Metered Dose Inhaler
14.6.3 Dry Powder Inhaler
14.6.4 Others
14.7 Basis Point Share (BPS) Analysis By Device Type
14.8 Absolute $ Opportunity Assessment By Device Type
14.9 Market Attractiveness Analysis By Device Type
14.10 Middle East & Africa (MEA) Oral Inhalation Devices Market Size Forecast By Application
14.10.1 Asthma
14.10.2 Chronic Obstructive Pulmonary Disease (COPD)
14.10.3 Others
14.11 Basis Point Share (BPS) Analysis By Application
14.12 Absolute $ Opportunity Assessment By Application
14.13 Market Attractiveness Analysis By Application
14.14 Middle East & Africa (MEA) Oral Inhalation Devices Market Size Forecast By Distribution Channel
14.14.1 Retail Pharmacy
14.14.2 Hospital Pharmacy
14.14.3 Online Pharmacy
14.15 Basis Point Share (BPS) Analysis By Distribution Channel
14.16 Absolute $ Opportunity Assessment By Distribution Channel
14.17 Market Attractiveness Analysis By Distribution Channel
Chapter 15 Competition Landscape
15.1 Oral Inhalation Devices Market: Competitive Dashboard
15.2 Global Oral Inhalation Devices Market: Market Share Analysis, 2021
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Koninklijke Philips N.V.
15.3.2 AptarGroup, Inc.
15.3.3 Chiesi Farmaceutici S.p.A.
15.3.4 OMRON Healthcare, Inc.
15.3.5 Recipharm AB
15.3.6 KINDEVA DRUG DELIVERY
15.3.7 Beurer GmbH
15.3.8 PARI Respiratory Equipment, Inc.
15.3.9 Vincent Medical Holdings Limited
15.3.10 Trudell Medical International (Monaghan Medical Corporation)
Methodology
Related Reports
Some other reports from this category!
Our Clients
